Bloomberg ran a piece on the Pox-Protein Public Private Partnership (P5) and their plans to improve on the RV144 Thai HIV vaccine trial results. Check it out, http://www.bloomberg.com/news/2012-06-26/shark-oil-for-aids-takes-cue-fr....

In its World AIDS Vaccine Day statement, the Public Health Agency of Canada noted that through the Canadian HIV Vaccine Intiative, five new research teams are dedicating their work to accelerating HIV vaccine R&D, which is helping to strengthen the links between Canadian and other researchers around the world.  

In an editorial published in the Mail & Guardian, Michel Sidibe, Chidi Nweneka and Margaret McGlynn wrote that despite the advances in the management of HIV, an effective vaccine to prevent HIV would save billions.  The full piece can be found here, http://mg.co.za/article/2012-05-18-vaccine-is-the-best-hope-against-aids.

The U.S. Military HIV Research Program issued a statement by COL. Nelson Michael highlighting the Military's efforts to develop a globally effective HIV vaccine.  The statement is available here, http://www.hivresearch.org/news.php?NewsID=240&GlobalID=11. 

Enterprise stakeholders are conducting activities/events all around the world to commemorate HIV Vaccine Awareness Day, 18 May.  Check out our comprehensive listing of activities going on this week, http://www.vaccineenterprise.org/content/HVAD2012.   We hope you will show your support and participate in one or many!

The OCTAVE Project, the South African MRC, HVTN and SCHARP are soliciting applications for a workshop  for YECIs on key statistical considerations for the design and analysis of HIV vaccine trials. Click the PDF below for more details.

 RFA: New OCTAVE Workshop for Young and Early Career

New vaccine research suggests that scientists are homing in on the critical ingredients of a protective HIV vaccine and identifies new HIV vaccine candidates to test in human clinical trials. Read more here...

The African AIDS Vaccine Parntership (AAVP) held a satellite session at AIDS Vaccine 2011 in Bangkok, Thailand to review its new strategic direction and seek input on strategies to enhance AAVP’s relevance in Africa.  The full meeting report is below.

The Canadian HIV Vaccine Initiative (CHVI) announced that the International Centre for Infectious Diseases (ICID) will house the new Canadian HIV Vaccine Initiative (CHVI) Research and Development Alliance Coordinating Office (ACO). The ACO will provide support, establish networks, offer leadership in innovation to accelerate efforts to develop a vaccine.  The full announcement is located here (http://www.hc-sc.gc.ca/ahc-asc/media/nr-cp/_2011/2011_161-eng.php).

IAVI, The Scripps Research Institute, Theraclone Sciences and Monogram Biosciences (a LabCorp company), published in the journal, Nature, today the discovery of 17 new broadly neutralizing antibodies against HIV. Together these discoveries with other recent discoveries in the neutralizing antibody arena represent tremendous progress in this area of AIDS vaccine research.  The IAVI announcement is available below.